The Cell-Free Way

Noninvasive prenatal testing of cell-free fetal DNA isolated from maternal blood performed better than standard biochemical serum screening methods for detecting fetal aneuploidies, as fewer false-positive cases were reported, researchers from Tufts Medical Center, Illumina, and elsewhere write in the New England Journal of Medicine this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."